Cargando…

RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma

Pirarubicin (THP) is a new generation cell cycle nonspecific anthracycline anticancer drug. Pirarubicin and pirarubicin-based combination therapies have been demonstrated to be effective against HCC in TACE. However, the drug resistance limits its therapeutic efficacy. Receptor-interacting protein k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hechen, Chen, Tianchi, Zhou, Yuan, Geng, Lei, Shen, Tian, Zhou, Lin, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299408/ https://www.ncbi.nlm.nih.gov/pubmed/30588188 http://dx.doi.org/10.7150/ijms.28289

Ejemplares similares

HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways
por: Chen, Tianchi, et al.
Publicado: (2018)

Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma
por: He, Xiaodong, et al.
Publicado: (2014)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019)

HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma
por: Chen, Tianchi, et al.
Publicado: (2019)

Transarterial chemoembolization with pirarubicin-eluting microspheres in patients with unresectable hepatocellular carcinoma: Preliminary results
por: Bai, Mingjun, et al.
Publicado: (2019)

TNF-dependent hyperactivation of RIPK1-dependent cytotoxic signaling during embryogenesis and inflammation
por: Mocarski, Edward S., et al.
Publicado: (2021)

Scutellarein regulates the PTEN/AKT/NFκB signaling pathway to reduce pirarubicin related liver inflammation
por: Lan, Ying, et al.
Publicado: (2023)

Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia
por: Lv, Suqin, et al.
Publicado: (2019)

Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis
por: Chen, Da-Yin, et al.
Publicado: (2020)

Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways
por: Zhang, Yang, et al.
Publicado: (2023)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases.
por: Ramirez, L. H., et al.
Publicado: (1993)

Membrane Transport and Antitumor Activity of Pirarubicin, and Comparison with Those of Doxorubicin
por: Sugiyama, Tomomi, et al.
Publicado: (1999)

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer
por: Zhang, Chao, et al.
Publicado: (2022)

Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E
por: Zhang, Ying, et al.
Publicado: (2021)

YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
por: Zhou, Yuan, et al.
Publicado: (2019)

In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
por: Chen, Gang, et al.
Publicado: (2012)

Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2015)

Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer
por: Jiang, Bo, et al.
Publicado: (2017)

5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells
por: Tian, Fang, et al.
Publicado: (2016)

Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis
por: Mulay, Shrikant R., et al.
Publicado: (2016)

Retracted: Inhibition of miR-15a-5p Promotes the Chemoresistance to Pirarubicin in Hepatocellular Carcinoma via Targeting eIF4E
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: a single-institution retrospective analysis
por: Saito, Shiro, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma
por: Gao, Xingxing, et al.
Publicado: (2022)

Characteristics of the Inhibitory Effect of Mitoxantrone and Pirarubicin on Lung Metastases of Colon Carcinoma 26
por: Iigo, Masaaki, et al.
Publicado: (1995)

Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin
por: Liu, Weifang, et al.
Publicado: (2021)

RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system
por: Li, Dianrong, et al.
Publicado: (2017)

T cell–derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death
por: Chun, Nicholas, et al.
Publicado: (2021)

Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2020)

Reducing oxidative stress may be important for treating pirarubicin-induced cardiotoxicity with schisandrin B
por: Tang, Heng, et al.
Publicado: (2022)

Antitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit V x 2 tumour model.
por: Okada, M., et al.
Publicado: (1995)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin-Induced Hepatotoxicity
por: Shi, Hongwei, et al.
Publicado: (2022)

RIPK4 Suppresses the Invasion and Metastasis of Hepatocellular Carcinoma by Inhibiting the Phosphorylation of STAT3
por: Li, Haoran, et al.
Publicado: (2021)

Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway
por: Fei, Junjie, et al.
Publicado: (2019)

MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury
por: Wang, Qiang, et al.
Publicado: (2022)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

Possibility of Contribution of Nucleoside Transport Systems to Pirarubicin Uptake by HL60 Cells but Not Mononuclear Cells
por: Nagasawa, Kazuki, et al.
Publicado: (1998)

Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report
por: Kato, Yutaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s8ehul9oveoc2bfmm0fbtf6c2b